These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3986422)

  • 41. Choosing the appropriate sclerosing concentration for vessel diameter.
    Sadick NS
    Dermatol Surg; 2010 Jun; 36 Suppl 2():976-81. PubMed ID: 20590703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Telangiectases].
    Davy A; Ouvry P
    Phlebologie; 1984; 37(4):549-60. PubMed ID: 6514805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Surgery or sclerosing treatment of the superficial cutaneous venous network].
    Goldschmidt-Clermont
    Phlebologie; 1974; 27(1):95-101. PubMed ID: 4427935
    [No Abstract]   [Full Text] [Related]  

  • 44. Aesthetic treatment of leg veins.
    Vitale-Lewis VA
    Aesthet Surg J; 2008; 28(5):573-83. PubMed ID: 19083582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Micro-sclero-electrotherapy].
    Brizzio EO
    Phlebologie; 1991; 44(1):207-11. PubMed ID: 1946646
    [No Abstract]   [Full Text] [Related]  

  • 46. Compression in the treatment of leg telangiectasia: theoretical considerations.
    Goldman MP
    J Dermatol Surg Oncol; 1989 Feb; 15(2):184-8. PubMed ID: 2644328
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Setting up a vein treatment center--incorporating sclerotherapy into the dermatologic practice.
    Duffy DM
    Semin Dermatol; 1993 Jun; 12(2):150-8. PubMed ID: 8512795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial.
    Bertanha M; Camargo PA; Moura R; Yoshida WB; Pimenta RE; Mariúba JV; Alcantara GP; de Paula DR; Sobreira ML
    Medicine (Baltimore); 2016 Sep; 95(39):e4812. PubMed ID: 27684809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of reticular veins and telangiectases.
    Smith PC
    Phlebology; 2015 Nov; 30(2 Suppl):46-52. PubMed ID: 26556703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The sclerotherapy of telangiectasia.
    Ouvry PA; Davy A
    Phlebologie; 1982; 35(1):349-59. PubMed ID: 7071184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sclerotherapy of spider veins using the accurate depth-gauge collagen needle.
    El-Azhary RA; Weick JA
    Int J Dermatol; 2008 Feb; 47(2):205-6. PubMed ID: 18211501
    [No Abstract]   [Full Text] [Related]  

  • 52. Scrutinizing sclerotherapy.
    Bowman WE
    N C Med J; 1996; 57(3):127-8. PubMed ID: 8935354
    [No Abstract]   [Full Text] [Related]  

  • 53. Sclerotherapy for superficial venules and telangiectasias of the lower extremities.
    Goldman PM
    Dermatol Clin; 1987 Apr; 5(2):369-79. PubMed ID: 3581522
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dermoscopy-assisted sclerotherapy for spider leg veins.
    AlJasser MI; Lui H
    Dermatol Surg; 2014 Feb; 40(2):217-8. PubMed ID: 24238372
    [No Abstract]   [Full Text] [Related]  

  • 55. Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study.
    Iannitti T; Rottigni V; Torricelli F; Palmieri B
    Clin Appl Thromb Hemost; 2014 Apr; 20(3):326-30. PubMed ID: 23076772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reasons for ulceration after injection treatment of telangiectasia.
    Bihari I; Magyar E
    Dermatol Surg; 2001 Feb; 27(2):133-6. PubMed ID: 11207685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liquid versus foam sclerotherapy.
    Hamel-Desnos C; Allaert FA
    Phlebology; 2009 Dec; 24(6):240-6. PubMed ID: 19952379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An unusual local reaction after microsclerotherapy with chromated glycerin.
    Corazza M; Zampino MR; Lauriola MM; Vecchiati G; Virgili A
    Dermatitis; 2006 Dec; 17(4):198-200. PubMed ID: 17150170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Commentary: Choosing the appropriate sclerosing concentration for vessel diameter.
    Palm MD
    Dermatol Surg; 2010 Jun; 36 Suppl 2():982. PubMed ID: 20590704
    [No Abstract]   [Full Text] [Related]  

  • 60. Microsclerotherapy.
    Guex JJ
    Semin Dermatol; 1993 Jun; 12(2):129-34. PubMed ID: 8512793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.